OASYS NOW
OASYS NOW is a European healthtech company providing AI-powered patient screening and data pseudonymisation solutions to accelerate clinical trials and enable privacy-first healthcare research. Their key products include ELaiGIBLE, which automates patient eligibility screening from unstructured medical data in real-time, and De-ID, a certified pseudonymisation tool for structured and unstructured health data ensuring GDPR compliance. The company integrates with major EHR systems like ChipSoft HiX and Epic, supports multiple data standards, and uses advanced AI and cryptographic techniques to handle complex health data securely. OASYS NOW's technology reduces clinical trial recruitment time from months to minutes, increases trial inclusivity and site capacity, and is certified to ISO 27001 and NEN 7510 standards. They have strong traction with leading hospitals and research centers in Europe, aiming to impact 100 million patients in five years, and are recognized with EU awards and major investment prizes.
OASYS NOW
OASYS NOW is a European healthtech company providing AI-powered patient screening and data pseudonymisation solutions to accelerate clinical trials and enable privacy-first healthcare research. Their key products include ELaiGIBLE, which automates patient eligibility screening from unstructured medical data in real-time, and De-ID, a certified pseudonymisation tool for structured and unstructured health data ensuring GDPR compliance. The company integrates with major EHR systems like ChipSoft HiX and Epic, supports multiple data standards, and uses advanced AI and cryptographic techniques to handle complex health data securely. OASYS NOW's technology reduces clinical trial recruitment time from months to minutes, increases trial inclusivity and site capacity, and is certified to ISO 27001 and NEN 7510 standards. They have strong traction with leading hospitals and research centers in Europe, aiming to impact 100 million patients in five years, and are recognized with EU awards and major investment prizes.
TL;DR
What they do: AI-powered patient screening and data pseudonymisation for clinical trials
Headquarters: Delft, Netherlands
Key products: ELaiGIBLE (eligibility screening) and De-ID (pseudonymisation)
Compliance & security: ISO 27001 and NEN 7510 certified
Recent funding: Seed round (Nov 22, 2024)
Company Overview
Problem Domain
Clinical-trial recruitment, patient matching, data pseudonymisation for privacy-preserving health research
Founded
2021
Industry
Healthtech / Medtech
Tech Stack
Funding Track Record
Investor Signal
“Backed by early-stage investors including Cherry Ventures, General Catalyst, ASIF Ventures, TenNine VC, Golden Egg Check Capital, Graduate Entrepreneur Fund; YES!Delft provides non-equity support”